A mole inside your eye is almost certainly a choroidal nevus, a flat collection of pigmented cells in the tissue lining the back of your eye. These are found in roughly 6% of the adult white population, and the vast majority never cause any problems at all.1Clinical and Experimental Optometry. The MOLES system to guide the management of melanocytic choroidal tumours: can optometrists apply it? The rare concern is that a choroidal nevus could eventually transform into uveal melanoma, but the actual risk of that happening is extremely low, and eye doctors have well-established tools for telling the difference.
What an Eye Mole Actually Is
Just as your skin contains melanocytes that sometimes cluster into visible moles, the interior of your eye has melanocytes too. When those pigment-producing cells gather in the choroid, the vascular layer between the retina and the white outer wall of the eye, the result is a choroidal nevus. It looks like a small, usually flat, gray or brownish spot on the back of your eye. Most people never know they have one until an eye care provider spots it during a routine dilated exam.
Not every eye “freckle” sits in the choroid. Some appear on the conjunctiva, the clear tissue that covers the white part of your eye, and those are visible without any special instruments. Conjunctival nevi tend to be tan or brown spots that people can actually see in a mirror, and they occasionally change color slightly over the years. In rare cases, a conjunctival nevus has been partially removed and the remaining tissue spontaneously regressed on its own.2PubMed. Unusual melanocytic nevi of the conjunctiva Other pigmented spots inside the eye can mimic a nevus on imaging but turn out to be something different entirely, such as congenital hypertrophy of the retinal pigment epithelium, a flat, benign lesion that shows a characteristic pattern on high-resolution scans.3Retina. Enhanced Depth Imaging Optical Coherence Tomography of Intraocular Tumors
How Common Are Eye Moles, and Who Gets Them
Choroidal nevi are one of the most common intraocular tumors. The roughly 6% prevalence figure comes from studies of adult white populations, but actual numbers vary depending on how carefully eyes are examined and which population is studied. Many nevi are subtle enough that they go undetected unless a clinician is specifically looking with modern imaging. That means the true prevalence could be higher than what surveys report.
Fair skin, light-colored irises, and a tendency to sunburn are all associated with a greater likelihood of having pigmented lesions inside the eye, which mirrors what we see with skin moles. There is no reliable evidence that eye moles are more common in one sex than the other, and they can appear at almost any age, though they are most frequently noticed in middle-aged adults simply because that is when people tend to get thorough eye exams.
When Should You Actually Worry
The short version: a small, flat, stable choroidal nevus with no associated features is a “watch and wait” situation, and most people will watch for years without anything happening. Choroidal melanoma, the cancer that an eye mole could theoretically become, is rare, occurring at a rate of roughly 5 to 10 cases per million people per year.1Clinical and Experimental Optometry. The MOLES system to guide the management of melanocytic choroidal tumours: can optometrists apply it? That figure puts it in the “genuinely uncommon” category, but because the consequences of a missed melanoma are serious, eye doctors take even a small risk seriously.
Ophthalmologists use a set of clinical risk factors to decide how worried to be about a given lesion. The most widely used checklist goes by the acronym TFSOM-DIM, which stands for the features that predict growth over five years:
- Thickness: greater than 2 mm on ultrasound
- Subretinal fluid: visible on optical coherence tomography (OCT)
- Symptoms: vision loss to 20/50 or worse
- Orange pigment: seen on autofluorescence imaging
- Melanoma hollowness: a characteristic low-reflectivity pattern on ultrasound
- Diameter: greater than 5 mm on fundus photography
Each factor present adds to the overall risk score. A lesion with none of these features has roughly a 1% chance of growing over five years. A lesion with five of the six features has about a 55% five-year growth rate.4Scientific Reports. Performance of the MOLES and TFSOM-DIM scores in classifying choroidal nevi and melanoma Growth does not automatically equal cancer, but it is the strongest signal that something needs closer attention or intervention.
A newer scoring system called MOLES was designed to simplify decision-making, especially for optometrists who might be the first to spot a lesion. In one large tertiary-center study, the MOLES score allowed clinicians to safely discharge over 200 patients back to their community optometrists without the prolonged monitoring that the older system required. The median follow-up needed under MOLES was zero years for low-risk lesions, compared to two years under the older index.5Eye. Real-world experience of implementing the MOLES score in a virtual choroidal naevi clinic at a tertiary referral centre If your eye doctor tells you your mole scores low on a risk checklist and suggests an annual photo to track it, that is the standard approach and a genuinely reassuring sign.
What Happens at a Monitoring Appointment
Your first visit after a choroidal nevus is discovered typically involves a dilated exam and fundus photography, a high-resolution photo of the back of your eye that creates a baseline image. Many clinics also perform OCT, which produces a cross-sectional scan of the retina and underlying tissue. These two tools together can reveal subretinal fluid and measure the lesion’s borders without any discomfort beyond the dilation drops.
If the mole is larger or has any borderline features, your eye doctor may refer you to an ocular oncologist or retinal specialist. That appointment often adds an ultrasound of the eye, which measures the lesion’s thickness precisely and can detect internal reflectivity patterns that help distinguish a benign nevus from something more concerning. In primary care settings where not every imaging tool is available, clinicians are encouraged to refer any lesion wider than 5 mm, any lesion with subretinal fluid, or any lesion too thick to measure with standard OCT.6PubMed Central. Choroidal Nevus Features Associated with Subspecialty Referral
Monitoring intervals depend on risk level. A tiny, flat, featureless nevus might only need a photo comparison once a year. A larger or thicker lesion with one or two risk factors may warrant visits every three to six months. The goal is always the same: catch any change early enough that treatment can preserve as much vision and health as possible.
The Connection Between Skin Moles and Eye Melanoma
This is an area of real clinical interest. People with many atypical skin moles, sometimes called dysplastic nevi, appear to have a higher risk of developing melanoma inside the eye as well. In a study of patients with ocular melanoma, about a third had more than five dysplastic skin nevi, compared to just over 1% in the general population.7Ophthalmologica. Ocular Melanoma: Epidemiology, Clinical Presentation and Relationship with Dysplastic Nevi The same study found that the lifetime risk of developing a skin melanoma in addition to an eye melanoma was roughly three times the general population’s baseline risk.
That does not mean every person with a lot of moles on their skin needs to panic about their eyes. What it does suggest is that melanocyte biology is partly systemic: if your body tends to produce atypical pigmented lesions in one tissue, it may do the same elsewhere. If you have a known history of atypical skin moles or a family history of melanoma, it is worth mentioning to your eye care provider. The overlap between dermatological and ophthalmological risk is something clinicians are increasingly paying attention to.
UV Exposure and Protecting Your Eyes
Ultraviolet light is a well-established driver of melanoma on the skin, but the relationship between UV exposure and melanoma inside the eye is less straightforward. Research has confirmed that solar UV radiation is the main causative factor for squamous tumors on the eye’s outer surface, with incidence rates rising the closer a population lives to the equator.8PubMed Central. A UV-related risk analysis in ophthalmic malignancies: Increased UV exposure may cause ocular malignancies For choroidal melanoma specifically, the evidence is less definitive, though several epidemiological studies have noted associations with chronic sun exposure and lighter eye color.
Regardless of where the science lands on causation, protecting your eyes from UV makes sense for multiple reasons. A good pair of sunglasses does not just dim bright light. Testing of sunglass lenses has shown that they can absorb essentially all erythemally weighted UV radiation, blocking over 99.5% regardless of lens tint.9Journal of Exposure Science & Environmental Epidemiology. Sun exposure to the eyes: predicted UV protection effectiveness of various sunglasses Wraparound styles offer even more protection because they block UV that enters from the sides. Wide-brimmed hats reduce the total UV dose reaching your eyes as well. Even if the link between UV and choroidal melanoma remains debated, UV protection prevents cataracts, pterygium, and surface cancers that are firmly linked to sun exposure.
What Happens If an Eye Mole Does Turn Out to Be Melanoma
If monitoring reveals that a lesion is growing or has features strongly suggestive of melanoma, the treatment approach depends on the tumor’s size and location. The vast majority of uveal melanomas are treated with some form of radiation rather than surgical removal of the eye. Plaque brachytherapy, where a small radioactive disc is surgically placed on the outside of the eye directly over the tumor, is the most common approach for small to medium tumors. Proton beam therapy and stereotactic radiosurgery are alternatives that deliver external beams of radiation with high precision.10PubMed. Radiation therapy for uveal melanoma: a review of treatment methods available in 2021
Not all radiation approaches perform equally. Comparative data has shown that certain radioactive isotopes used in plaque therapy carry a higher risk of local tumor recurrence than others. One study found that ruthenium-106 plaques carried roughly three times the recurrence risk compared to iodine-125 plaques or proton beam therapy.11PubMed. Comparison of episcleral plaque and proton beam radiation therapy for the treatment of choroidal melanoma These differences influence which treatment a specialist recommends, along with tumor thickness, location relative to the optic nerve, and the patient’s visual goals.
Enucleation, the surgical removal of the entire eye, is reserved for the largest tumors or those that have not responded to radiation. It sounds dramatic, and it is, but it remains a life-saving option when the tumor is too large or too poorly positioned for radiation to be effective. The good news is that modern detection and monitoring mean most uveal melanomas are caught when they are still small enough for eye-conserving treatment.
The Psychological Side of Being Monitored
Something that does not get enough attention is the emotional toll of long-term surveillance. Being told you have a spot in your eye that probably will not become cancer but needs to be checked every six to twelve months creates a peculiar kind of anxiety. You are not sick, you are not being treated, but you are not quite off the hook either. Recent commentary in the ophthalmology literature has argued that observation should be reframed as an intervention in its own right, one that carries real costs including patient burden, psychological harm, and cascades of additional testing that are rarely accounted for when monitoring protocols are designed.12PubMed. Observation burden: why surveillance in ophthalmology deserves the same scrutiny as treatment
If you find yourself anxious between appointments, that is a normal and recognized response, not something to dismiss. Talk to your eye care provider about what specific changes would actually trigger concern, so you have a concrete mental framework rather than a vague sense of dread. Knowing that your lesion scored zero on a risk scale and that the next step is simply an annual photo can be genuinely calming once you internalize what those details mean. Some patients also benefit from knowing the actual numbers: a lesion with no risk factors has about a 1% chance of growing over five years, which means a 99% chance of staying exactly the same.
Eye Moles in Children
Choroidal nevi are uncommon in children, and when pigmented lesions are found in a child’s eye, the diagnostic thought process is different. The range of tumors that affect children’s eyes includes benign growths as well as malignancies that are distinct from the melanomas seen in adults. Early identification matters because some pediatric eye tumors are vision-threatening or life-threatening, but the specific concern about a benign nevus transforming into melanoma is primarily an adult issue.13Pediatric Clinics of North America. Tumors of the Eye and Orbit in Children If a pigmented spot is found in a child’s eye during a routine exam, a pediatric ophthalmologist is the right specialist to evaluate it.
How Artificial Intelligence Is Changing Detection
One of the harder clinical problems in ocular oncology is distinguishing a small choroidal melanoma from a large choroidal nevus. The two can look remarkably similar on imaging, and the traditional risk-factor checklists, while useful, leave a gray zone in the middle where experienced clinicians sometimes disagree. Machine learning models are starting to fill that gap.
One model trained on clinical variables like subretinal fluid, tumor height, distance from the optic disc, and orange pigment achieved strong predictive performance in separating small melanomas from nevi over a two-year follow-up window.14PubMed Central. Artificial intelligence for ocular oncology Another approach used deep learning on ultrasound and ultra-widefield imaging to predict tumor thickness, a key risk factor, with high sensitivity and specificity.15PubMed Central. Predicting Malignant Transformation of Choroidal Nevi Using Machine Learning These tools are not replacing eye doctors, but they are being developed as decision-support systems that could help clinicians, especially those outside major academic centers, make more confident calls about borderline lesions.16PubMed Central. Artificial intelligence in the diagnosis of uveal melanoma: advances and applications
For patients, this means the diagnostic pipeline is likely to get more precise over time. A future where your eye mole photo is analyzed by both a human specialist and an AI model trained on thousands of similar cases is not far off, and it could reduce both the number of unnecessary referrals and the number of missed early melanomas. The technology is still in development and validation stages, but the trajectory is encouraging.